http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PT-89474-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56
filingDate 1989-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24a2284fbc3d4b0265fed26426b142f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90e3d8101ec7e8db7adad3e9ab73304b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d0c18feb63d970deec3e29f841afb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a71a977c3ddc55965ac1037aa9363ce5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12664253b9ca1b8fd38706605c460f0e
publicationDate 1993-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PT-89474-B
titleOfInvention PROCESS FOR THE PREPARATION OF SALTS OF CEFALOSPORIN AND INJECTABLE COMPOSITIONS THAT CONTAIN THEM
abstract Crystalline sulfuric, di-nitric, mono-hydrochloric, di-hydrochloric, and di- and sesqui-orthosphosphoric acid addition salts of 7-[ alpha -(2-aminothiazol-4-yl)- alpha -(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinio)methyl]-3-ceph em-4-carboxylate are stable even at elevated temperatures. The crystalline sulfuric acid addition salt is made by forming an admixture of (a) at least one molar equivalent of sulfuric acid with (b) zwitterion in an amount so as to be present in the admixture at a concentration of greater than 25 milligrams/ml, causing crystallization, separating the crystals, washing and drying. The crystalline monohydrochloride, dihydrochloride, and orthophosphate salts are prepared by dissolving the zwitterion in the appropriate amount of acid, causing crystallization by adding acetone and isolating the crystals. Physical admixtures of the salts with certain bases in proportions to give a pH ranging from about 3.5 to about 7 on dilution with water provide injectable compositions on dilution.
priorityDate 1988-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453950635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21873664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160328685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452458000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452107106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409242494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5742673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22605900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426126735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448186497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6994333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453887929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004

Total number of triples: 68.